Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.
Saved in:
| Title: | Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. |
|---|---|
| Authors: | Sabate, Manel, Cequier, Angel, Iñiguez, Andrés, Serra, Antonio, Hernandez-Antolin, Rosana, Mainar, Vicente, Valgimigli, Marco, Tespili, Maurizio, den Heijer, Pieter, Bethencourt, Armando, Vazquez, Nicolas, Gómez-Hospital, Joan Antoni, Baz, José Antonio, Martin-Yuste, Victoria, van Geuns, Robert-Jan, Alfonso, Fernando, Bordes, Pascual, Tebaldi, Matteo, Masotti, Monica, Silvestro, Antonio |
| Source: | Lancet. 10/27/2012, Vol. 380 Issue 9852, p1482-1490. 9p. |
| Subjects: | Surgical stents, Myocardial infarction, Coronary restenosis, Medical statistics, Medical screening, Patients |
| Abstract: | The article offers information regarding comparison of different stent in patients with ST-segment elevation myocardial infarction (STEMI). It mentions uses of everolimus-eluting stent (EES) that reduces risk of restenosis in percutaneous coronary intervention. It presents a study conducted on patients with STEMI. It also discusses the controversial usage of drug-eluting stent in patients with STEMI. INSET: Panel: Research in context. |
| Database: | Psychology and Behavioral Sciences Collection |
Be the first to leave a comment!
